Table 5.
BCVA | Baseline | Month 1 | Month 3 | Month 6 | Month 7 | Month 9 | Month 12 |
---|---|---|---|---|---|---|---|
20/20 or better | 42 (42%) | 35 (39%) | 40 (43%) | 42 (46%) | 43 (50%) | 40 (43%) | 43 (47%) |
20/40 or better | 83 (84%) | 75 (84%) | 79 (84%) | 80 (88%) | 74 (86%) | 80 (86%) | 79 (86%) |
20/80 or better | 93 (94%) | 83 (93%) | 90 (96%) | 87 (96%) | 81 (94%) | 88 (95%) | 88 (96%) |
20/100 or better | 94 (95%) | 85 (96%) | 92 (98%) | 89 (98%) | 83 (97%) | 89 (96%) | 90 (98%) |
20/200 or better | 99 (100%) | 89 (100%) | 94 (100%) | 91 (100%) | 86 (100%) | 92 (99%) | 92 (100%) |
20/400 or better | 99 (100%) | 89 (100%) | 94 (100%) | 91 (100%) | 86 (100%) | 93 (100%) | 92 (100%) |
Worse than 20/400 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
N (BCVA available) | 99 | 89 | 94 | 91 | 86 | 93 | 92 |
Baseline last available measurement before implantation, BCVA best corrected visual acuity